Literature DB >> 18816111

Gedunin, a novel hsp90 inhibitor: semisynthesis of derivatives and preliminary structure-activity relationships.

Gary E L Brandt1, Matthew D Schmidt, Thomas E Prisinzano, Brian S J Blagg.   

Abstract

Gedunin (1), a tetranortriterpenoid isolated from the Indian neem tree ( Azadirachta indica), was recently shown to manifest anticancer activity via inhibition of the 90 kDa heat shock protein (Hsp90) folding machinery and to induce the degradation of Hsp90-dependent client proteins similar to other Hsp90 inhibitors. The mechanism of action by which gedunin induces client protein degradation remains undetermined, however, prior studies have demonstrated that it does not bind competitively versus ATP. In an effort to further probe the mechanism of action, 19 semisynthetic derivatives of gedunin were prepared and their antiproliferative activity against MCF-7 and SkBr3 breast cancer cells determined. Although no compound was found to exhibit antiproliferative activity more effective than the natural product, functionalities critical for antiproliferative activity have been identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18816111      PMCID: PMC2850591          DOI: 10.1021/jm8007486

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Heat shock protein 90 as a molecular target for cancer therapeutics.

Authors:  Jennifer S Isaacs; Wanping Xu; Len Neckers
Journal:  Cancer Cell       Date:  2003-03       Impact factor: 31.743

Review 2.  Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery.

Authors:  William B Pratt; David O Toft
Journal:  Exp Biol Med (Maywood)       Date:  2003-02

Review 3.  Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement.

Authors:  William B Pratt; Mario D Galigniana; Jennifer M Harrell; Donald B DeFranco
Journal:  Cell Signal       Date:  2004-08       Impact factor: 4.315

4.  Effect of neem limonoids on lactate dehydrogenase (LDH) of the rice leaffolder, Cnaphalocrocis medinalis (Guenée) (Insecta: Lepidoptera: Pyralidae).

Authors:  Sengottayan Senthil Nathan; Kandaswamy Kalaivani; Paul Gene Chung; Kadarkarai Murugan
Journal:  Chemosphere       Date:  2005-09-12       Impact factor: 7.086

Review 5.  Molecular mechanisms of multidrug resistance in cancer chemotherapy.

Authors:  K Nooter; G Stoter
Journal:  Pathol Res Pract       Date:  1996-07       Impact factor: 3.250

Review 6.  Role of quinones in toxicology.

Authors:  J L Bolton; M A Trush; T M Penning; G Dryhurst; T J Monks
Journal:  Chem Res Toxicol       Date:  2000-03       Impact factor: 3.739

Review 7.  Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation.

Authors:  Brian S J Blagg; Timothy D Kerr
Journal:  Med Res Rev       Date:  2006-05       Impact factor: 12.944

8.  Isolation and characterization of an antimalarial agent of the neem tree Azadirachta indica.

Authors:  S A Khalid; H Duddeck; M Gonzalez-Sierra
Journal:  J Nat Prod       Date:  1989 Sep-Oct       Impact factor: 4.050

Review 9.  Pharmacological strategies for overcoming multidrug resistance.

Authors:  S Nobili; I Landini; B Giglioni; E Mini
Journal:  Curr Drug Targets       Date:  2006-07       Impact factor: 3.465

Review 10.  What makes tumors multidrug resistant?

Authors:  Piet Borst; Jos Jonkers; Sven Rottenberg
Journal:  Cell Cycle       Date:  2007-08-23       Impact factor: 4.534

View more
  29 in total

1.  Alternative approaches to Hsp90 modulation for the treatment of cancer.

Authors:  Jessica A Hall; Leah K Forsberg; Brian S J Blagg
Journal:  Future Med Chem       Date:  2014-09       Impact factor: 3.808

Review 2.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 3.  Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.

Authors:  Gaurav Garg; Anuj Khandelwal; Brian S J Blagg
Journal:  Adv Cancer Res       Date:  2016-02-10       Impact factor: 6.242

Review 4.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

5.  Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis.

Authors:  Chaitanya A Patwardhan; Abdul Fauq; Laura B Peterson; Charles Miller; Brian S J Blagg; Ahmed Chadli
Journal:  J Biol Chem       Date:  2013-01-25       Impact factor: 5.157

6.  Synthesis of the bridging framework of phragmalin-type limonoids.

Authors:  Terry P Lebold; Gary M Gallego; Christopher J Marth; Richmond Sarpong
Journal:  Org Lett       Date:  2012-04-03       Impact factor: 6.005

Review 7.  Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents.

Authors:  Reen-Yen Kuo; Keduo Qian; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Nat Prod Rep       Date:  2009-08-13       Impact factor: 13.423

8.  Identification of a novel "almost neutral" micro-opioid receptor antagonist in CHO cells expressing the cloned human mu-opioid receptor.

Authors:  Elliott J Sally; Heng Xu; Christina M Dersch; Ling-Wei Hsin; Li-Te Chang; Thomas E Prisinzano; Denise S Simpson; Denise Giuvelis; Kenner C Rice; Arthur E Jacobson; Kejun Cheng; Edward J Bilsky; Richard B Rothman
Journal:  Synapse       Date:  2010-04       Impact factor: 2.562

9.  Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.

Authors:  Daniel Paris; Nowell J Ganey; Vincent Laporte; Nikunj S Patel; David Beaulieu-Abdelahad; Corbin Bachmeier; Amelia March; Ghania Ait-Ghezala; Michael J Mullan
Journal:  J Neuroinflammation       Date:  2010-03-08       Impact factor: 8.322

10.  Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.

Authors:  Puranik Purushottamachar; Abhijit M Godbole; Lalji K Gediya; Marlena S Martin; Tadas S Vasaitis; Andrew K Kwegyir-Afful; Senthilmurugan Ramalingam; Zeynep Ates-Alagoz; Vincent C O Njar
Journal:  J Med Chem       Date:  2013-06-07       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.